Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019

  02 January 2020

Lithuania reported an outbreak of carbapenem-resistant, and for some cases, colistin-resistant, Enterobacterales in November 2019. Between 1 February and 26 November 2019, 199 cases were detected, including cases with infection as well as carriage. The majority of cases (186 cases) occurred in one single hospital (Hospital 1). Most of the carbapenem-resistant Enterobacterales (CRE) isolates were Klebsiella pneumoniae (93%), followed by Escherichia coli. In all isolates, carbapenem resistance was mediated by a Klebsiella pneumoniae carbapenemase (KPC) enzyme.

Further reading: ECDC
Author(s): ECDC
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!